BioAtla Inc (BCAB)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$1.30+7.44%
Close 2026-09-03 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · BCAB
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | — | — | — | — | — | 0.3 | — |
| Total Revenues | — | — | — | — | — | 0.3 | — |
| Operating Expenses & Income | |||||||
| R&D Expenses | 25.5 | 43.6 | 63.1 | 103.7 | 79.3 | 58.3 | 19.9 |
| Operating Income | (32.1) | (59.3) | (73.9) | (129.7) | (108.1) | (96.4) | (30.1) |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | — | — | — | 0.0 | 0.0 | 1.4 |
| Interest & Investment Income | 0.3 | 0.8 | 3.4 | 6.3 | 1.6 | 0.4 | 0.1 |
| Net Interest Expenses | — | — | — | — | (1.6) | (0.3) | 1.3 |
| Income Tax Expense | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | |||||||
| Minority Interest | — | — | — | — | — | 0.0 | 0.0 |
| Net Income | 87.8 | (59.6) | (69.8) | 123.5 | (106.5) | (95.4) | (35.9) |
| Per Share | |||||||
| Basic EPS | 52.84 | (1.01) | (1.44) | (2.58) | (2.74) | (2.76) | — |
| Diluted EPS | 52.81 | (1.01) | (1.44) | (2.58) | (2.74) | (2.76) | — |
| Basic Weighted Avg Shares | 1.7 | 58.8 | 48.6 | 47.8 | 38.9 | 34.6 | — |
| Diluted Weighted Avg Shares | 1.7 | 58.8 | 48.6 | 47.8 | 38.9 | 34.6 | — |
| Supplemental | |||||||
| EBITDA | — | (58.9) | (73.0) | (128.5) | (106.9) | (95.1) | (29.1) |
| EBIT | (32.1) | (59.3) | (73.9) | (129.7) | (108.1) | (96.4) | (30.1) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.